Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

por Annunzio, Kaitlin, Grover, Natalie S., Welkie, Rina Li, Torka, Pallawi, Watkins, Marcus P., Anampa-Guzmán, Andrea, Tavakkoli, Montreh, Oh, Timothy S., Reves, Heather, Jones, Daniel, Hanel, Walter, Christian, Beth, Ramakrishnan Geethakumari, Praveen, Karmali, Reem, Barta, Stefan K., Bartlett, Nancy L., Olszewski, Adam J., Epperla, Narendranath
Publicado 2023

Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study

por Epperla, Narendranath, Welkie, Rina Li, Torka, Pallawi, Shouse, Geoffrey, Karmali, Reem, Shea, Lauren, Anampa-Guzmán, Andrea, Oh, Timothy S., Reaves, Heather, Tavakkoli, Montreh, Lindsey, Kathryn, Greenwell, Irl Brian, Hansinger, Emily, Thomas, Colin, Chowdhury, Sayan Mullick, Annunzio, Kaitlin, Christian, Beth, Barta, Stefan K., Geethakumari, Praveen Ramakrishnan, Bartlett, Nancy L., Herrera, Alex F., Grover, Natalie S., Olszewski, Adam J.
Publicado 2023

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma

por Hanel, Walter, Shindiapina, Polina, Bond, David A., Sawalha, Yazeed, Epperla, Narendranath, Voorhees, Timothy, Welkie, Rina Li, Huang, Ying, Behbehani, Gregory K., Zhang, Xiaoli, McLaughlin, Eric, Chan, Wing K., Brammer, Jonathan E., Jaglowski, Samantha, Reneau, John C., Christian, Beth A., William, Basem M., Cohen, Jonathon B., Baiocchi, Robert A., Maddocks, Kami, Blum, Kristie A., Alinari, Lapo
Publicado 2023